Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned under...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway interventions are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifelong Hypoxia Produces Multigenerational Developmental Lung Disease and Pulmonary Hypertension in Mice.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

An optimized "hypoxia in a pill" regimen reverses neurodegenerative disease phenotypes in multiple preclinical models.

bioRxiv : the preprint server for biology·2026
Same author

Gene-set and proteomic signatures associated with survival after in-hospital cardiac arrest.

Resuscitation plus·2026
Same author

Methemoglobin Formation Reflects Systemic Nitric Oxide Uptake: The Critical Role of Delivery Method-Results from Secondary Analysis of a Randomized Controlled Trial.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Inhaled nitric oxide at 300 ppm treats multidrug-resistant <i>Pseudomonas</i> pneumonia in swine and is safe in humans.

Science translational medicine·2026
Same author

Effects of Continuous Low-dose Nitric Oxide in a Murine Model of Pulmonary Hypertension with Impaired Lung Development.

Anesthesiology·2026

Related Experiment Video

Updated: May 15, 2026

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
07:02

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

Improving outcomes after cardiac arrest using NO inhalation.

Fumito Ichinose1

  • 1Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. fichinose@partners.org

Trends in Cardiovascular Medicine
|January 8, 2013
PubMed
Summary

Inhaled nitric oxide (NO) may improve neurological outcomes and survival after sudden cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). This approach avoids systemic vasodilation, offering a potential new therapy for post-CA patients.

More Related Videos

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Related Experiment Videos

Last Updated: May 15, 2026

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
07:02

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Area of Science:

  • Cardiology
  • Neurology
  • Critical Care Medicine

Background:

  • Sudden cardiac arrest (CA) and cardiopulmonary resuscitation (CPR) are associated with dismal long-term neurological outcomes and survival rates.
  • Therapeutic hypothermia (TH) has shown limited success in improving these outcomes.
  • Nitric oxide (NO) has organ-protective effects against ischemia-reperfusion (I/R) injury, but systemic administration is limited by vasodilation in hypotensive post-CA patients.

Purpose of the Study:

  • To evaluate the potential of inhaled nitric oxide (NO) as a therapeutic strategy to improve neurological outcomes and survival after CA and CPR.
  • To investigate whether inhaled NO can provide systemic benefits without causing detrimental systemic vasodilation in the post-CA setting.

Main Methods:

  • Pre-clinical and clinical studies investigating the systemic effects of inhaled NO.
  • Assessment of NO's impact on brain injury and neurological function post-CPR.
  • Evaluation of hemodynamic stability (blood pressure) during inhaled NO administration in post-CA models.

Main Results:

  • Inhaled NO demonstrates systemic benefits in various studies.
  • Unlike intravenous NO-donors, inhaled NO does not cause significant systemic vasodilation.
  • Potential for inhaled NO to mitigate post-CA brain injury.

Conclusions:

  • Inhaled nitric oxide (NO) presents a promising therapeutic avenue for improving outcomes after sudden cardiac arrest (CA) and cardiopulmonary resuscitation (CPR).
  • Its ability to provide systemic benefits without systemic vasodilation makes it a potentially safer alternative for hypotensive post-CA patients.
  • Further research into inhaled NO could lead to improved long-term neurological recovery and survival rates following CA.